Use of Dexmedetomidine as Adjuvant for the Anesthetic Management of Obese Children with Obstructive Sleep Apnea Undergoing Tonsillectomy and Adenoidectomy

Hdl Handle:
http://hdl.handle.net/10675.2/934
Title:
Use of Dexmedetomidine as Adjuvant for the Anesthetic Management of Obese Children with Obstructive Sleep Apnea Undergoing Tonsillectomy and Adenoidectomy
Authors:
Mendiola, Raul A.; Florentino-Pineda, Ivan
Abstract:
Obstructive sleep apnea (OSA) in children is most commonly associated with tonsillar and adenoid hypertrophy. Use of opioids and residual amounts of inhaled agents can cause severe respiratory depression and thus represent an added risk to patients with OSA in the immediate postoperative period. Dexmedetomidine, a specific alpha 2-adrenergic receptor agonist, is known for its hypnotic, sedative, analgesic and sympatholytic properties. It potentiates analgesia with the advantages of minimal respiratory compromise, rapid onset and clearance. Because dexmedetomidine has been shown to be effective as an analgesic and sedative agent while minimizing respiratory compromise, it offers a safer alternative as an adjuvant for the anesthetic management of obese pediatric patients with OSA undergoing tonsillectomy and adenoidectomy.
Publisher:
Society for Pediatric Anesthesia
Issue Date:
Mar-2009
URI:
http://hdl.handle.net/10675.2/934
Language:
en_US
Description:
Poster - Case Report
Series/Report no.:
SPA;2009-P03
Appears in Collections:
Department of Anesthesiology and Perioperative Medicine: Faculty Research and Presentaions

Full metadata record

DC FieldValue Language
dc.contributor.authorMendiola, Raul A.-
dc.contributor.authorFlorentino-Pineda, Ivan-
dc.date.accessioned2013-02-08T23:39:33Z-
dc.date.available2013-02-08T23:39:33Z-
dc.date.issued2009-03-
dc.identifier.urihttp://hdl.handle.net/10675.2/934-
dc.descriptionPoster - Case Reporten_US
dc.description.abstractObstructive sleep apnea (OSA) in children is most commonly associated with tonsillar and adenoid hypertrophy. Use of opioids and residual amounts of inhaled agents can cause severe respiratory depression and thus represent an added risk to patients with OSA in the immediate postoperative period. Dexmedetomidine, a specific alpha 2-adrenergic receptor agonist, is known for its hypnotic, sedative, analgesic and sympatholytic properties. It potentiates analgesia with the advantages of minimal respiratory compromise, rapid onset and clearance. Because dexmedetomidine has been shown to be effective as an analgesic and sedative agent while minimizing respiratory compromise, it offers a safer alternative as an adjuvant for the anesthetic management of obese pediatric patients with OSA undergoing tonsillectomy and adenoidectomy.en_US
dc.language.isoen_USen_US
dc.publisherSociety for Pediatric Anesthesiaen_US
dc.relation.ispartofseriesSPA;2009-P03-
dc.subjectAnesthesiaen_US
dc.subjectPediatricen_US
dc.subjectdexmedetomidineen_US
dc.subjectsleep apneaen_US
dc.titleUse of Dexmedetomidine as Adjuvant for the Anesthetic Management of Obese Children with Obstructive Sleep Apnea Undergoing Tonsillectomy and Adenoidectomyen_US
dc.contributor.corporatenameDepartment of Anesthesiology and Perioperative Medicineen_US
All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.